Search results for "DDR1"

showing 4 items of 4 documents

Discoidin domain receptor 1 gene variants are associated with decreased white matter fractional anisotropy and decreased processing speed in schizoph…

2019

Abstract DDR1 has been linked to schizophrenia (SZ) and myelination. Here, we tested whether DDR1 variants in people at risk for SZ influence white matter (WM) structural variations and cognitive processing speed (PS). First, following a case-control design (Study 1), SZ patients (N = 1193) and controls (N = 1839) were genotyped for rs1264323 and rs2267641 at DDR1, and the frequencies were compared. We replicated the association between DDR1 and SZ (rs1264323, adjusted P = 0.015). Carriers of the rs1264323AA combined with the rs2267641AC or CC genotype are at risk to develop SZ compared to the other genotype combinations. Second, SZ patients (Study 2, N = 194) underwent an evaluation of PS …

AdultMalemedicine.medical_specialtyTrail Making TestBiologyPolymorphism Single NucleotideWhite matter03 medical and health sciences0302 clinical medicineDiscoidin Domain Receptor 1Internal medicineGenotypeFractional anisotropymedicineHumansCognitive DysfunctionGenotypingBiological PsychiatryDDR1Middle Agedmedicine.diseaseMagnetic Resonance ImagingWhite Matter030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologySchizophreniaSpainCase-Control StudiesSchizophreniaFemale030217 neurology & neurosurgeryDiscoidin domainJournal of psychiatric research
researchProduct

Liver fibrosis: Direct antifibrotic agents and targeted therapies

2018

Liver fibrosis and in particular cirrhosis are the major causes of morbidity and mortality of patients with chronic liver disease. Their prevention or reversal have become major endpoints in clinical trials with novel liver specific drugs. Remarkable progress has been made with therapies that efficiently address the cause of the underlying liver disease, as in chronic hepatitis B and C. Highly effective antiviral therapy can prevent progression or even induce reversal in the majority of patients, but such treatment remains elusive for the majority of liver patients with advanced alcoholic or nonalcoholic steatohepatitis, genetic or autoimmune liver diseases. Moreover, drugs that would speed…

Liver Cirrhosis0301 basic medicineCirrhosisDiseaseChronic liver disease03 medical and health sciencesLiver diseaseTransforming Growth Factor betaFibrosisAnimalsHumansMedicineMolecular Targeted TherapyMolecular BiologyExtracellular Matrix ProteinsDDR1business.industrymedicine.disease3. Good healthBiomarker (cell)030104 developmental biologyDisease ProgressionCancer researchHepatic stellate cellbusinessSignal TransductionMatrix Biology
researchProduct

Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prost…

2020

Background TP53 plays critical roles in sensitivity to chemotherapy, and aging. Collagen is very important in aging. The molecular structure and biochemical properties of collagen changes during aging. The discoidin domain receptor (DDR1) is regulated in part by collagen. Elucidating the links between TP53 and DDR1 in chemosensitivity and aging could improve therapies against cancer and aging. Results Restoration of WT-TP53 activity resulted in increased sensitivity to chemotherapeutic drugs and elevated expression of key components of the Raf/MEK/ERK, PI3K/Akt and DDR1 pathways. DDR1 could modulate the levels of Raf/MEK/ERK and PI3K/Akt pathways as well as sensitize the cells to chemothera…

MAPK/ERK pathwayMalecollagenAgingRAF/MEK/ERKMAP Kinase Signaling SystemAntineoplastic Agentsdiscoidin domain receptor (DDR1)DDRCollagen receptorPhosphatidylinositol 3-KinasesDiscoidin Domain Receptor 1Cell Line TumorHumansRapamycinTP53ReceptorProtein kinase BPI3K/AKT/mTOR pathwayDDR1ChemistryWild typeProstateProstatic NeoplasmschemoresistanceCell Biologyprostate cancerDrug Resistance NeoplasmMutationCancer researchraf KinasesTumor Suppressor Protein p53Discoidin domainResearch Paper
researchProduct

The role of NFkappaB inducing kinase (NIK) in the pathogenicity of EAE

2014

pathways (PTPN6, SLC3A2, VAV3, DDR1) and modulators of oxidative stress (MT1A, HMOX1, SLC30A1) were also significantly affected by the CBD treatment. The microarray results were confirmed using qPCR on selected gene targets. Immunoblotting demonstrated that CBD reduces IL-17 by decreasing STAT3 phosphorylation and increasing that of STAT5. In conclusion, our observations increase our understanding of the mechanisms of the anti-inflammatory activities of CBD.

VAV3DDR1MicroarrayKinaseImmunologyPTPN6Biologymedicine.disease_causedigestive systemdigestive system diseasesCell biologysurgical procedures operativeNeurologybiology.proteinmedicineImmunology and AllergyPhosphorylationNeurology (clinical)STAT3Oxidative stressJournal of Neuroimmunology
researchProduct